CellSource Co Ltd 4880
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 1,526.00
- Day Range
- JPY 1,497.00–1,567.00
- 52-Week Range
- JPY 1,179.00–3,180.00
- Bid/Ask
- JPY 1,516.00 / JPY 1,525.00
- Market Cap
- JPY 30.04 Bil
- Volume/Avg
- 103,700 / 202,704
Key Statistics
- Price/Earnings (Normalized)
- 34.27
- Price/Sales
- 6.41
- Dividend Yield (Trailing)
- 0.32%
- Dividend Yield (Forward)
- 0.64%
- Total Yield
- 0.33%
Company Profile
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 196
- Website
- https://www.cellsource.co.jp
Comparables
Valuation
|
Metric
|
4880
|
9341
|
6523
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.27 | 10.58 | 5.91 |
Price/Book Value | 5.07 | 4.38 | 1.15 |
Price/Sales | 6.41 | 2.80 | 0.41 |
Price/Cash Flow | 47.72 | 12.03 | 3.77 |
Price/Earnings
4880
9341
6523
Financial Strength
|
Metric
|
4880
|
9341
|
6523
|
|---|---|---|---|
Quick Ratio | 7.99 | 4.27 | 0.82 |
Current Ratio | 8.61 | 4.34 | 1.31 |
Interest Coverage | 1,488.74 | 4,212.64 | −0.43 |
Quick Ratio
4880
9341
6523
Profitability
|
Metric
|
4880
|
9341
|
6523
|
|---|---|---|---|
Return on Assets (Normalized) | 19.12% | 37.98% | 1.01% |
Return on Equity (Normalized) | 21.49% | 49.46% | 4.11% |
Return on Invested Capital (Normalized) | 21.42% | 48.75% | 4.17% |
Return on Assets
4880
9341
6523
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qvhsyyvj | Hkxf | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Wpxybzptg | Tqqsp | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bfzctzp | Qkptz | $99.5 Bil | |
MRNA
| Moderna Inc | Vpkgklwl | Dty | $38.8 Bil | |
ARGX
| argenx SE ADR | Vgcrcgqp | Dtnzd | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Flftgfxrz | Jxrmr | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Yhkssqb | Twjysf | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Wsvpxbpzw | Qwqkby | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Lwlszmszss | Xptsvcj | $12.5 Bil | |
INCY
| Incyte Corp | Bgwjhnqh | Ftyvm | $11.6 Bil |